HTLV-1 tax oncoprotein represses the p53-mediated trans-activation function through coactivator CBP sequestration

Oncogene. 2000 Mar 16;19(12):1491-9. doi: 10.1038/sj.onc.1203450.

Abstract

The human T-cell leukemia virus type 1 (HTLV-1) Tax oncoprotein repressed the transcriptional activity of wild-type p53 through its N-terminal trans-activation domain. Although Tax did not directly bind to p53, this repression required the activation of CREB pathway by Tax. In contrast to a recent report by Pise-Masison et al. (1998a, b) we found that the phosphorylation of p53 on Ser 15 is not a major cause of the Tax-mediated inactivation of p53. However, Tax with a mutation in the coactivator CBP-binding site (K88A), which activates NF-kappaB but not the CREB pathway, could not repress the p53 trans-activation function. Moreover, Tax inhibited p53 binding to CBP in vitro and inhibited synergistic activation of transcription by CBP and p53. Thus, Tax is likely to compete with p53 in binding with CBP, thereby repressing its trans-activation function.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Binding, Competitive
  • CREB-Binding Protein
  • Cell Line
  • Cyclic AMP Response Element-Binding Protein / metabolism
  • Gene Products, tax / genetics
  • Gene Products, tax / metabolism*
  • Gene Silencing
  • Humans
  • NF-kappa B / metabolism
  • Nuclear Proteins / genetics
  • Nuclear Proteins / metabolism*
  • Phosphorylation
  • Trans-Activators / genetics
  • Trans-Activators / metabolism*
  • Transcription, Genetic
  • Tumor Suppressor Protein p53 / genetics
  • Tumor Suppressor Protein p53 / metabolism*

Substances

  • Cyclic AMP Response Element-Binding Protein
  • Gene Products, tax
  • NF-kappa B
  • Nuclear Proteins
  • Trans-Activators
  • Tumor Suppressor Protein p53
  • CREB-Binding Protein
  • CREBBP protein, human